- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Potentially Undervalued Companies
Norwegian Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED Apr 24, 2024
Companies with a Value score of at least 3, ordered by Value score
6 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
NAVA | kr34.20 | 2.1% | -7.3% | kr596.2m | kr49.00 | PE156.3x | E30.8% | n/a | ||
NORD | kr41.00 | 0% | n/a | kr203.8m | n/a | PE2x | n/a | 0% | ||
VISTN | kr23.50 | -2.5% | 7.3% | kr1.0b | n/a | PE18.5x | n/a | 4.3% | ||
PHO | kr54.40 | 0.9% | 1.9% | kr1.5b | kr86.00 | PE5522.7x | E88.3% | 0% | ||
ULTI | kr7.58 | -9.3% | -94.0% | kr260.8m | kr6.50 | PB0.9x | E14.4% | n/a | ||
CRNA | kr2.84 | 1.4% | -83.7% | kr21.6m | kr48.00 | PS2.2x | E88.1% | n/a |
Page 1 of 1